Amenorrhea Dr.Zainab A.A.Jaafar

1. AmenorrheaDr.ZainabA.A.Jaafar

2. Objective: At the end of this lecture, the 5th year student should be able to • Define the primary amenorrhea • Understands the clinical types of primary amenorrhea • Understands the causes of primary amenorrhea • State line of management of primary amenorrhea • Describe the clinical feature and management of TURNER’S SYNDROME (45X AND MOSAICS)

3. Definition: Amenorrhea: defined as the absence of menses

4. Clinical types: Physiological: • Primary: Before puberty • Secondary: During pregnancy, lactation, menopause Pathological • primary • secondary

5. Definition: • Primary amenorrhea: when girls fail to menstruate by 16 years of age. Irrespective of the presence or absence of secondary sexual characteristics (the girl has never menstruated before)

6. Definition: • Secondary amenorrhoea: is absence of menstruation for more than 6 months in a normal female of reproductive age who had menses previously and that is not due to pregnancy, lactation or the menopause.

7. Definition: There are at least five basic factors involved in the onset and continuation of normal menstruation. • Normal female chromosomal pattern (46XX). • Coordinated hypothalamopituitary ovarian axis. • Anatomical presence and patency of the outflow tract. • Responsive endometrium. • Active support of thyroid and adrenal glands.

9. Etiology: is classified according to the presence or absence of secondary sexual characteristics

10. I. Absent breast development; uterus present Gonadal failure: • 45,X (Turner syndrome) • 46,X, abnormal X (e.g., short- or long-arm deletion) • Mosaicism (e.g., X/XX, X/XX,XXX) • 46,XX or 46,XY pure gonadal dysgene • 17α-hydroxylase deficiency with 46,XX,CAH

11. I. Absent breast development; uterus presentHypothalamic failure secondary to inadequate GnRH release • Insufficient GnRH secretion because of neurotransmitter defect • Congenital ( Isolated gonadotrophin-relesasing hormone deficiency- Kallmann’s syndrome) • Congenital anatomic defect in central nervous system • CNS neoplasm (craniopharyngioma)

12. I. Absent breast development; uterus presentPituitary failure • Isolated gonadotrophin insufficiency (thalassemia major, retinitis pigmentosa) • Pituitary neoplasia (adenoma) • Mumps, encephalitis • Newborn kernicterus • Prepubertal hypothyroidism

13. II. Breast development; uterus absent • Androgen insensitivity syndrome (Testicular feminization syndrome), 46 XY • Congenital Absence of the Uterus (Uterine Agenesis, Uterovaginal Agenesis, Mayer-Rokitansky-Küster-Hauser Syndrome)

14. III. Absent breast development; uterus absent • 17, 20 desmolase deficiency • 17 hydroxylase deficiency with 46,XY karyotype • Agonadism

15. IV. Breast development; uterus present • Constitutional delay • Hormonal • Hypothalamic and pituitary dysfunction —eg. Stress, weight loss, excessive exercise, anorexia nervosa, chronic systemic disease (eg.tuberculosis). • approximately 25% of these individuals had hyperprolactinemia and prolactinomas

16. IV. Breast development; uterus present • Developmental defect of genital tract • Imperforate hymen. • Transverse vaginal septum. • endocrine • Metabolic disorders • Juvenile diabetes.

17. IV. Breast development; uterus present • Systemic illness • Malnutrition, anemia • Weight loss • Tuberculosis. • Unresponsive endometrium • Congenital • Uterine synechiae (tubercular).

18. Investigations: investigation is started if • No periods by 16 years but secondary sexual characters are present. • No periods by 14 years in the absence of secondary sexual characters.

19. History • Aske other stages of puberty: Growth spurt, axillary and pubic hair, breast development(Lack of pubertal development suggests an ovarian/pituitary failure or a chromosomal abnormality)

20. History • cyclical abdominal pain and sometimes urinary retention suggestive of outflow obstruction • Clinical features of virilizationeg. hirsutism • Recent changes in weight( loss or gain) within short of time ,exercise habits, or recent life events causing stress

21. History • History of visual field defects • Past medical diseases :eg. cushing syndrome, tuberculosis or diabetes ,Any neonatal and childhood diseases( eg.Neonatal crisis, suggestive of adrenal cause)

22. History • sexual history • drug history, e.g. use of metoclopramide, antipsychotics, previous radiotherapy and chemotherapy • family history of the same problem (of delayed menarche) in the family or absent puberty

23. Examination: • height, weight, BMI • examine for secondary sexual characteristic*( eg.breast growth,pubic and underarm hair • feature of endocrine diseases( Hirsutism, acne, striae, increased pigmentation • Vitiligo—may be seen associated with autoimmune conditions of ovarian failure

24. Examination: • Breast examine: • development • galactorrhea • Stigmata of chromosomal abnormalities eg.Features of Turner’s syndrome—low hairline, webbed neck, widely spaced nipples. • Abdominal examination for masses .

25. Examination: Genital examination: • pubertal hair development • Clitoral size(clitoromegaly) • inspect the vulva for any abnormality such as • 1- Tense bulging bluish membrane (imperforated hymen) • 2-vaginal septum • pelvic examination not indicated in sexually in active female so we do rectal examination :for the Presence of cervix and uterus

26. Examination: Visual field exam Assess visual fields and CNS examination (Kallmann syndrome or pituitary tumor)

27. Investigation • The first step in the work-up of primary and secondary amenorrhea is a pregnancy test • Bone X-ray’s for age estimation. • Pelvic ultrasound - Rarely may need MRI or CT of the abdomen scanning to assess pelvic anatomy. • for presence or absence of the uterus and ovaries • to detect hematocolpos and hematometra

28. Investigation • karyotype: • 46XY :Andogen Insensitivity (TSF syndrome) • 45X0 –turner syndrome • LH, FSH: • Elevated LH, FSH: Hypergonadotropic Hypogonadism ( eg.gonadal dysgenesis) • Low LH, FSH: Hypogonadotropic hypogonadism (intracranial leasion)

29. Investigation • Prolactin levels:Elevatedindicates Prolactinoma • X-ray or CT or MRI imagingof pituitary fossa : to rule pituitary tumors • Ovarian biopsy if suspect Resistant ovary syndrome. Histopathology illustrating absence of oocytes

30. Investigation • Thyroid function test(T3,T4,TSH) • GnRH stimulation test: If GnRH administered • increase pituitary gonadotropins( LH FSH) is the probable cause is hypothalamic dysfunction • no rise of gonadotropins( LH FSH): pituitary disorders

31. Investigation • serum progesteron: • high serum progesteron: sent for 17-OH-progesterone ,Urinary pregnanetriol and cortisol • Low serum progesteron: Resistant ovary syndrome ,Gonadal agenesis

32. Management Is based on the etiology, and the presence or absence of secondary sexual characteristics.

33. Management • If constitutional delay and secondary sexual characteristics are complete no need to suggest any treatment apart from annual review until she has menstruation, some use COC pills to promote menstruation as this will reassure her that menstruation can occur..

34. Management Outflow obstruction: Surgical management • Imperforate hymen; cruciate incision of the hymen or hymenectomy. • Transverse Vaginal Septum; Excision of the septum depending on its level within the vagina.

36. Management Absent uterus: • Girl managed by special psychological counseling as she got problem regarding their future sexual activity & infertility. • Vagina is created at appropriate time (Vaginoplasty ) by surgical or non- surgical way using vaginal dilators. • Girl with XY Karyotype: The gonads should be removed after puberty( Gonadectomy ). because of increased development of seminoma or dysgerminoma

37. Management • Turner’s syndrome:short-term use of estrogen and progesterone at least for the development of secondary sex characters

38. Hypothalamic-pituitary ovarian axis defect • Severe defect may not respond • isolated gonadotropin deficiency (like Kallmann’s syndrome) responds to pulsatile GnRH (for ovulation) and estrogen, progesterone (for menstruation) • Hypothalamic-pituitary tumors eg.(craniopharyngioma) may need surgical excision or radiotherapy • If pituitary microadenoma: then treatment is with Bromocriptine or Cabergoline, macroadenoma may necessitate surgery or radiotherapy

39. Management • Thyroid and adrenal diseases: • (Cretinism) do not respond to thyroxin. Mild hypothyroids respond well • Adrenogenital syndrome with enlarged clitoris treated by excise clitoris (clitoroplasty) as early as possible to avoid psychological trauma • Corticosteroids are useful in17 α hydroxylase deficiency

40. Management • Metabolic and nutritional diseases: • Hypoglycemic agents and insulin in case of diabetics • Anti-TB treatment for TB • Anemia treatment • Malabsorption to be treated • Adequate nutrition in case of weight loss

41. Management • Unresponsive endometrium: – For TB synechiae: Adhesiolysis followed by incretion of IUCD and high dose of estrogen and progesterone to control for withdrawal bleeding – Receptor abnormal—no treatment

42. TURNER’S SYNDROME (45X AND MOSAICS) • This is probably the commonest abnormality in females involving the sex chromosomes. Although 1 in 2500 live-born girls are affected, most pregnancies with this abnormality miscarry, probably secondary to major cardiac defects. • Turner syndrome (45,X) is characterized :

44. TURNER’S SYNDROME (45X AND MOSAICS) • The most common genotype is 45,X, which is accompanied by nonfunctional streak ovaries and primary amenorrhea • Mosaicism (45,X/46,XX) may occur; these women may have some ovarian function through early adulthood, and may become pregnant, but then progress to secondary amenorrhea

45. TURNER’S SYNDROME (45X AND MOSAICS) At birth by: • low weight • short stature • edema of the hands and feet • Loose skin folds on the neck.

46. Adolescent patients have : • Growth failure: low birth weight and short stature; • ovarian failure: no secondary sexual development in most cases • occasionally secondary amenorrhea in mosaicism; • a low posterior hairline • webbed neck • prominent ears

47. inverted, widely spaced nipples, and shield chest • epicanthal folds • renal dysgenesis; • left-sided cardiac malformations, coarctation of the aorta; • distortion of the Eustachian tube leading to otitis media; • nail dysplasia; • eye deformities.

48. increased carrying angle at the elbow • cubitus valgus; • short fourth metacarpal; • high, arched palate, micrognathia and defective dental development; • Streak gonads: do not need to be removed as there is no Y chromosome present and no risk of malignancy. • Intelligence is usually normal, but there is risk of impairment of non-verbal skills, e.g. maths

49. Treatment: The physician should start growth hormone at age of 10 year and a very low dose of estrogen usually started after the age of 12 to encourage steady growth of the breasts; as high dose of estrogen promotes epiphyseal fusion, which stops further growth. The dose of estrogen is gradu­ally increased over 2 years.

50. Treatment: • The uterus will respond to estrogen therapy,once adult size uterus is found and ET more than 5 mm we start progesteron cyclically to produce regular endometrial shedding